The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I/II dose-escalation and expansion study of afuresertib + carboplatin and paclitaxel in recurrent ovarian cancer.
 
Sarah Patricia Blagden
Speakers' Bureau - Nucana
Research Funding - Merck Serono (Inst)
Patents, Royalties, Other Intellectual Property - Imperial College London
Travel, Accommodations, Expenses - Nucana
 
Hani Gabra
Research Funding - GlaxoSmithKline (Inst)
Patents, Royalties, Other Intellectual Property - Imperial College London
 
Anne L. Hamilton
Research Funding - Amgen (Inst); GlaxoSmithKline (Inst); Janssen (Inst); Lilly (Inst)
 
Shirley S. Wong
No Relationships to Disclose
 
Agnieszka Michael
Research Funding - Pfizer (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Pfizer
 
Linda R. Mileshkin
Research Funding - Hospira
Travel, Accommodations, Expenses - Merck Sharp & Dohme
 
Marcia Hall
No Relationships to Disclose
 
Jeffrey Goh
Stock and Other Ownership Interests - Icon Cancer Care
Consulting or Advisory Role - Bristol-Myers Squibb; Novartis; Roche
Speakers' Bureau - Novartis
Travel, Accommodations, Expenses - Amgen; MSD
 
Alla Sergeevua Lisyanskaya
No Relationships to Disclose
 
Michelle DeSilvio
Employment - GlaxoSmithKline; Novartis
Stock and Other Ownership Interests - GlaxoSmithKline; Novartis
 
Dany Habr
Employment - Novartis
Leadership - Novartis
Stock and Other Ownership Interests - Novartis
 
Shelby Gainer
Employment - GlaxoSmithKline; Novartis
Stock and Other Ownership Interests - GlaxoSmithKline; Novartis
 
Prashanth Gopalakrishna
Employment - Novartis
 
Tarek Meniawy
Research Funding - Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); Merck (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD